This rapidly expanding cancer patient group benefits of specialist care. The use of frailty assessment tools is mandatory in clinical practice and in medical reporting. A fair risk-benefits balance should be kept in mind at all times; patients' requests and expectations should be prioritised. Aggressive surgical treatment should not be neglected in principle, but alterative management should be considered at all times.
Copyright (c) 2010 Elsevier Ltd. All rights reserved.